Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis, improving vascular elasticity and protecting heart and cerebral vessels and preparation method thereof

A Chinese medicine composition using kudzu root and other herbs addresses the root causes of hypertension by promoting blood circulation and improving vascular elasticity, offering a safer and more effective treatment for cardiovascular diseases.

CN119074885APending Publication Date: 2024-12-06刘神剑
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411286655.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Conventional treatments for hypertension and cardiovascular diseases primarily focus on symptom relief rather than addressing the root cause, often causing harm and failing to improve vascular elasticity or balance hormonal regulation.

Method used

A Chinese medicine composition comprising kudzu root, eucommia leaves, peach kernels, angelica, earthworm protein, eucommia male flowers, double roses, sophora japonica flowers, gastrodia elata, tempeh, turmeric rhizomes, and saffron, prepared by washing, drying, crushing, sieving, extracting, and mixing these ingredients to promote blood circulation, remove blood stasis, and protect cardiovascular and cerebrovascular vessels.

Benefits of technology

The composition effectively promotes blood circulation, improves vascular elasticity, reduces thrombosis risk, and protects cardiovascular and cerebrovascular health, providing a safer and more holistic approach than conventional drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119074885A_ABST
    Figure CN119074885A_ABST
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for promoting blood circulation to remove blood stasis, improving vascular elasticity and protecting heart and cerebral vessels and a preparation method thereof, and relates to the technical field of health care products. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 1.0 to 2.0 parts of radix puerariae, 1.0 to 2.0 parts of folium cortex eucommiae, 0.5 to 1.5 parts of semen persicae, 0.5 to 1.0 part of radix angelicae sinensis, 0.5 to 1.0 part of earthworm protein, 0.5 to 1.0 part of cortex eucommiae male flowers, 0.5 to 1.0 part of flos rosae rugosae, 0.5 to 1.0 part of flos sophorae, 0.5 to 1.0 part of rhizoma gastrodiae, 0.5 to 1.0 part of tempeh, 0.5 to 1.0 part of rhizoma curcumae longae and 0.25 to 0.5 part of saffron crocus. According to the present invention, the common food, the three-new food and the medicinal and edible raw material formula are adopted, such that the effects of blood circulation promoting, blood stasis removing, microcirculation promoting, heart burden reducing, effective vascular elasticity improving, thrombus resistance, microcirculation enhancing, and heart and cerebral vessel protecting are provided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of health care products, in particular to a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving blood vessel elasticity and protecting cardiovascular and cerebrovascular vessels and a preparation method thereof. Background Art

[0002] There are many drawbacks in the way people deal with health problems. The conventional solution to health problems is to use drugs, but many drugs cannot cure the root cause and will cause a certain degree of harm to the body, which poses a great hidden danger to health.

[0003] Hypertension is a common cardiovascular disease. Most cases of hypertension have no definite cause and are related to multiple factors such as genetics, unhealthy lifestyles and the environment. Commonly used antihypertensive drugs only objectively reduce blood pressure by dilating blood vessels, which is a temporary solution but not a permanent cure. They also provide a supplementary solution to endocrine problems and fail to allow the body to automatically balance hormones. Therefore, we propose a Chinese medicine composition that can promote blood circulation and remove blood stasis, improve vascular elasticity, and protect cardiovascular and cerebrovascular systems, and a preparation method thereof, in order to solve the above problems.

[0004] The above information disclosed in this background technology is only used to increase the understanding of the background technology of the present invention and therefore, it may include information that does not constitute the prior art known to ordinary technicians in this field. Summary of the invention

[0005] The purpose of the present invention is to provide a Chinese medicine composition and a preparation method thereof for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels, so as to solve the problems raised by the above-mentioned background technology.

[0006] To achieve the above-mentioned purpose, the present invention provides the following technical scheme: a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving blood vessel elasticity, and protecting cardiovascular and cerebrovascular vessels, comprising the following raw materials in parts by weight: 1.0-2.0 parts of kudzu root, 1.0-2.0 parts of eucommia leaves, 0.5-1.5 parts of peach kernels, 0.5-1.0 parts of angelica sinensis, 0.5-1.0 parts of earthworm protein, 0.5-1.0 parts of eucommia male flowers, 0.5-1.0 parts of double roses, 0.5-1.0 parts of sophora japonica flowers, 0.5-1.0 parts of gastrodia elata, 0.5-1.0 parts of tempeh, 0.5-1.0 parts of turmeric rhizomes, and 0.25-0.5 parts of saffron.

[0007] A method for preparing a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels comprises the following steps:

[0008] Step 1: Select high-quality kudzu root, eucommia leaf, peach kernel, angelica, earthworm protein, eucommia male flower, double rose flower, Sophora japonica flower, Gastrodia elata, Tempeh, turmeric rhizome, and saffron, wash, dry, crush, and sieve them to obtain powdered raw materials, disinfect and sterilize them, and set them aside after passing the safety test;

[0009] Step 2, extracting each powdered raw material three times with water, mixing the three extracts, and then heating and concentrating them. After the concentration is completed, spray drying is performed to obtain each raw material powder;

[0010] Step 3: Mix the raw material powders evenly according to the proportion to obtain a mixed powder, then sterilize and disinfect it, and package it after testing to obtain the finished powder.

[0011] Preferably, in the step 1, each raw material is crushed and then passed through a 80-100 mesh sieve.

[0012] Preferably, in the step 2, the water extraction process comprises: extracting the powdered raw material with hot water at 80-95° C., filtering the liquid, and obtaining an extract.

[0013] Compared with the prior art, the present invention has the following beneficial effects:

[0014] The invention adopts common food, three new foods and medicine and food raw materials to form a formula, which has the effects of promoting blood circulation and removing blood stasis, promoting microcirculation, reducing the burden on the heart, effectively improving blood vessel elasticity, resisting thrombosis, enhancing microcirculation and protecting cardiovascular and cerebrovascular vessels.

[0015] The above summary is for illustrative purposes only and is not intended to be limiting in any way. In addition to the illustrative aspects, embodiments and features described above, further aspects, embodiments and features of the present invention will be readily apparent by reference to the accompanying drawings and the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 It is a schematic diagram of the preparation process of the present invention. DETAILED DESCRIPTION

[0017] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0018] See also Figure 1A Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels, comprising the following raw materials in parts by weight: 1.0-2.0 parts of Pueraria root, 1.0-2.0 parts of Eucommia ulmoides leaves, 0.5-1.5 parts of peach kernels, 0.5-1.0 parts of Angelica sinensis, 0.5-1.0 parts of earthworm protein, 0.5-1.0 parts of Eucommia ulmoides male flowers, 0.5-1.0 parts of double roses, 0.5-1.0 parts of Sophora japonica flowers, 0.5-1.0 parts of Gastrodia elata, 0.5-1.0 parts of Tempeh, 0.5-1.0 parts of Curcuma longa rhizomes, and 0.25-0.5 parts of Saffron.

[0019] Pueraria root: sweet and spicy, cool in nature, and enters the spleen and stomach meridians. Pueraria root total flavonoids can dilate coronary and cerebral blood vessels, increase coronary and cerebral blood flow, reduce myocardial oxygen consumption, and increase oxygen supply. Pueraria root can directly dilate blood vessels, reduce peripheral resistance, and has a significant antihypertensive effect, which can better relieve the "tight neck" symptoms of hypertensive patients. Puerarin can improve microcirculation, increase local microblood flow, and inhibit platelet aggregation.

[0020] Eucommia leaves: slightly spicy, warm in nature, enter the liver and kidney meridians, used for dizziness, sore waist and knees, weak muscles and bones, has sedative, analgesic, increases coronary blood flow, lowers blood pressure, anti-inflammatory, and uterine inhibition effects.

[0021] Peach kernel: bitter and sweet, neutral in nature, and enters the heart and liver meridians. Peach kernel extract can significantly increase cerebral blood flow, increase blood flow in the femoral artery of dogs, reduce vascular resistance, dilate blood vessels, inhibit platelet aggregation, inhibit blood cell coagulation and thrombosis, and improve blood rheology. It can improve animal liver surface microcirculation and promote bile secretion, and has liver protection and anti-liver fibrosis effects.

[0022] Angelica: Sweet and spicy, warm in nature, it enters the liver and heart meridians, has the effects of nourishing blood and activating blood circulation, regulating menstruation and relieving pain, moistening the intestines and relieving constipation, has the effect of dilating coronary arteries and increasing coronary blood flow, has the effect of lowering blood lipids, and has a certain protective effect on aortic lesions caused by arteriosclerosis. Ligustilide in angelica extract has the effect of inhibiting platelet aggregation. Angelica and its ferulic acid have obvious anti-thrombotic effects. Angelica polysaccharide has the effect of promoting hematopoietic function.

[0023] Earthworm protein: salty, cold in nature; enters the liver, spleen, and bladder meridians, has antihypertensive, anti-arrhythmic, and vascular elasticity effects, earthworm extract has anticoagulant and fibrinolytic effects, thereby inhibiting the formation of thrombus and promoting thrombus dissolution. Earthworm enzyme preparations can significantly reduce platelet aggregation, whole blood viscosity, and plasma viscosity, enhance red blood cell stability and red blood cell deformability, improve blood circulation, and have a good blood circulation and blood stasis effect.

[0024] Eucommia male flowers: sweet in taste, warm in nature, enter the liver and kidney meridians, have the effect of bidirectionally regulating blood pressure, strengthening the liver, tonifying the kidneys, promoting bowel movements, promoting sleep, and lowering the three highs.

[0025] Double rose flower: sweet, slightly bitter, warm in nature; it enters the liver meridian, has the effects of soothing the liver and lowering blood pressure, improving sleep, and activating blood circulation. Local application of the total extract can increase the blood flow rate of arterioles and accelerate the recovery of microcirculatory disorders.

[0026] Sophora japonica flower: bitter, slightly cold, enters the liver and large intestine meridians. Rutin in Sophora japonica flower can maintain the normal resistance of capillaries, reduce vascular permeability, and restore normal elasticity of capillaries that bleed due to increased fragility. Quercetin can reduce vascular permeability. It has the effects of reducing myocardial oxygen consumption, dilating coronary blood vessels, increasing coronary blood flow, resisting arrhythmia, and protecting heart function. It has a mild excitatory effect on the heart, increases the contractility and output of the heart, and reduces the heart rate. It has a significant effect of lowering blood pressure in a short time.

[0027] Gastrodia elata: sweet in taste, neutral in nature, enters the liver meridian, has the effects of reducing peripheral vascular, cerebral and coronary vascular resistance, and has the effects of lowering blood pressure, slowing heart rate, and relieving pain and inflammation.

[0028] Tempeh: It has the effects of increasing good fat, lowering cholesterol, anti-oxidation, and lowering blood sugar.

[0029] Turmeric rhizome: It tastes spicy and bitter, is cold in nature, and enters the spleen and liver meridians. It can lower serum cholesterol, triglycerides, low-density lipoprotein and other blood lipid levels, thereby reducing the risk of cardiovascular disease. Turmeric root contains a variety of ingredients such as turmeric ketone, aromatic turmeric ketone, eucalyptol, curcumin, etc. It has a certain analgesic effect and can relieve pain such as headaches and arthritis.

[0030] Saffron: sweet in taste, neutral in nature, enters the heart and liver meridians, has the effects of promoting blood circulation and removing blood stasis, relieving depression and relieving knots, cooling blood and detoxifying.

[0031] A method for preparing a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels comprises the following steps:

[0032] Step 1: Select high-quality kudzu root, eucommia leaf, peach kernel, angelica, earthworm protein, eucommia male flower, double rose flower, Sophora japonica flower, Gastrodia elata, Tempeh, turmeric rhizome, and saffron, wash, dry, crush, and sieve them to obtain powdered raw materials, disinfect and sterilize them, and set them aside after passing the safety test;

[0033] Specifically, each raw material is crushed and passed through a 80-100 mesh sieve;

[0034] Step 2, extracting each powdered raw material three times with water, mixing the three extracts, and then heating and concentrating them. After the concentration is completed, spray drying is performed to obtain each raw material powder;

[0035] Specifically, the water extraction process includes: extracting the powdered raw material with hot water at 80-95°C, filtering the liquid, and obtaining an extract;

[0036] Step 3: Mix the raw material powders evenly according to the proportion to obtain a mixed powder, then sterilize and disinfect it, and package it after testing to obtain the finished powder.

[0037] Dosage and Administration: Take one dose daily, 30 days as a course of treatment.

[0038] Embodiment 1

[0039] Prepare the following high-quality raw materials in parts by weight: 1.0 part of Pueraria root, 2.0 parts of Eucommia leaves, 1.0 part of peach kernels, 0.5 parts of Angelica sinensis, 0.5 parts of earthworm protein, 0.5 parts of Eucommia male flowers, 0.5 parts of double rose flowers, 1.0 parts of Sophora japonica flowers, 1.0 parts of Gastrodia elata, 1.0 parts of Tempeh, 1.0 parts of Curcuma longa rhizomes, and 0.5 parts of Saffron.

[0040] Step 1: Wash, dry, crush and sieve the above raw materials to obtain powdered raw materials, sterilize and sterilize them, and prepare them for use after passing the safety test;

[0041] Step 2: extract each powdered raw material three times, mix the three extracts, and then heat and concentrate them. After concentration, spray dry them to obtain powders of each raw material. Specifically, the water extraction process includes: extracting the powdered raw material with hot water at 80°C, filtering the liquid, and obtaining an extract;

[0042] Step 3: Mix the raw material powders evenly according to the proportion to obtain a mixed powder, then sterilize and disinfect it, and package it after testing to obtain the finished powder.

[0043] Embodiment 2

[0044] Prepare the following high-quality raw materials in parts by weight: 2.0 parts of Pueraria root, 1.0 parts of Eucommia leaves, 1.0 parts of peach kernels, 1.0 parts of Angelica sinensis, 1.0 parts of earthworm protein, 1.0 parts of Eucommia male flowers, 1.0 parts of double rose flowers, 0.5 parts of Sophora japonica flowers, 0.5 parts of Gastrodia elata, 0.5 parts of Tempeh, 0.5 parts of Curcuma longa rhizomes, and 0.5 parts of Saffron.

[0045] Step 1: Wash, dry, crush and sieve the above raw materials to obtain powdered raw materials, sterilize and sterilize them, and prepare them for use after passing the safety test;

[0046] Step 2: extract each powdered raw material three times, mix the three extracts, and then heat and concentrate them. After concentration, spray dry them to obtain powders of each raw material. Specifically, the water extraction process includes: extracting the powdered raw material with hot water at 90°C, filtering the liquid, and obtaining an extract;

[0047] Step 3: Mix the raw material powders evenly according to the proportion to obtain a mixed powder, then sterilize and disinfect it, and package it after testing to obtain the finished powder.

[0048] Embodiment 3

[0049] Prepare the following high-quality raw materials in parts by weight: 2.0 parts of Pueraria root, 2.0 parts of Eucommia leaf, 0.5 parts of peach kernel, 0.75 parts of Angelica sinensis, 0.75 parts of earthworm protein, 0.75 parts of Eucommia male flower, 0.75 parts of double rose, 0.75 parts of Sophora japonica flower, 0.75 parts of Gastrodia elata, 0.75 parts of Tempeh, 0.75 parts of Curcuma longa rhizome, and 0.25 parts of Saffron.

[0050] Step 1: Wash, dry, crush and sieve the above raw materials to obtain powdered raw materials, sterilize and sterilize them, and keep them ready for use after passing the safety test;

[0051] Step 2: Extract the powdered raw materials three times, mix the three extracts, and then heat and concentrate them. After concentration, spray-dry them to obtain powders of the raw materials. Specifically, the water extraction process includes: extracting the powdered raw materials with hot water at 95°C, filtering the extracts, and obtaining the extracts.

[0052] Step 3: Mix the raw material powders evenly according to the proportion to obtain a mixed powder, then sterilize and disinfect it, and package it after testing to obtain the finished powder.

[0053] To further verify the effect of the present invention, the following pharmacodynamic experiments were performed:

[0054] 1. Effects on blood rheology in rats with acute blood stasis model

[0055] Experimental animals: SD rats weighing 200-250 g, both male and female, were selected.

[0056] Experimental drugs: the powders of Example 1 (Group I), Example 2 (Group II), and Example 3 (Group III) of the present invention, each gram of which is equivalent to 1 gram of raw medicinal materials. The drugs were prepared with distilled water before the experiment and administered by gavage.

[0057] Experimental method: 50 SD rats, half male and half female, weighing 200-250g, were randomly divided into 5 groups, 10 rats in each group. The control group and the model group were gavaged with the same volume of physiological saline; the powder group I, II and III of the present invention were gavaged with 3g crude drug / kg respectively. The administration was continued for 7 days, once a day, and the dosage was 10ml / kg. Except for the blank control group, the other 4 groups were subcutaneously injected with 0.08ml / 100g of epinephrine on the 7th day, twice, with an interval of 4h. Between the two injections of epinephrine, the rats were immersed in 0℃ ice water for 5min, and then fasted. After 12 hours, blood was collected from the carotid artery under ether anesthesia, and heparin anticoagulation was used to determine the whole blood high shear (200s-1) and low shear viscosity (40s-1), erythrocyte sedimentation rate; the blood fibrinogen content was determined by thermal precipitation method; heparin anticoagulation blood was centrifuged to separate plasma, and plasma viscosity was determined; sodium citrate anticoagulation blood was taken again, and platelet adhesion rate was determined. The experimental results are shown below.

[0058] Table 1. Effects on blood rheology in rats with acute blood stasis model

[0059]

[0060] As can be seen from the above, the powder group I, group II and group III of the present invention can significantly increase the high shear rate and low shear rate viscosity of whole blood and plasma viscosity, increase blood fibrinogen, and increase platelet adhesion rate in rats with acute blood stasis model, which are significantly different from those of the control group (P<0.01); it can be seen that the present invention has a good effect of promoting blood circulation and removing blood stasis.

[0061] 2. Effects on vascular elasticity in middle-aged and elderly rats

[0062] Experimental animals: SD rats weighing 200-250 g, both male and female, were selected.

[0063] Experimental drugs: the powders of Example 1 (Group I), Example 2 (Group II), and Example 3 (Group III) of the present invention, each gram of which is equivalent to 1 gram of raw medicinal materials. The drugs were prepared with distilled water before the experiment and administered by gavage.

[0064] Experimental method: 90 SD rats, half male and half female, weighing 200-250g, were divided into 9 groups: a young control group of 4-5 months old; a middle-aged control group of 16 months old; middle-aged medication group I, group II and group III, all of which were fed with the powder of the present invention for 6 months from the age of 10 months; an elderly control group of 22 months old; elderly medication group I, group II and group III, all of which were fed with the powder of the present invention for 4 months from the age of 18 months.

[0065] The preparation and apparatus of the isolated thoracic aortic ring refer to the method of "Changes in the contractile and diastolic function of the thoracic aorta in rats with long-term denervation of the sinus arch" in the Chinese Journal of Pathophysiology. The contractile and diastolic tension of the arterial ring is directly read through the biofunctional experimental system. The specimen is preloaded with 2g and balanced for 1.5h. 0.2m of 10-4mol / 1 norepinephrine (NE) is added, and the maximum contraction amplitude of the arterial ring is recorded. Then rinse with KH solution, stabilize for 10min, add 0.2m of acetylcholine (Ach), and record the maximum relaxation degree of the arterial ring. Weigh the weight of the arterial ring after the experiment. There is no significant difference in the contractile effect caused by NE in each group, and the maximum diastolic tension caused by Ach is shown below.

[0066] Table 2. Effects on vascular elasticity in middle-aged and elderly rats

[0067]

[0068]

[0069] From the above, it can be seen that the middle-aged group was significantly weaker than the young control group (P<0.05), and the elderly group showed a decreasing trend; after the middle-aged and elderly rats took the powder of the present invention orally for 4 to 6 months, the relaxation ability of the aortic ring was improved, among which the middle-aged medication group I, group II and group III were significantly improved compared with the middle-aged control group (P<0.05); the elderly medication group I, group II and group III also showed an improvement trend compared with the elderly control group. It can be seen that long-term use of the present invention can significantly improve vascular relaxation function, thereby improving arterial elasticity.

[0070] 3. Effects on Microcirculatory Disorders in Mice

[0071] Experimental animals: Kunming mice weighing 18 to 22 g, both male and female, were selected.

[0072] Experimental drugs: the powders of Example 1 (Group I), Example 2 (Group II), and Example 3 (Group III) of the present invention, each gram of which is equivalent to 1 gram of raw medicinal materials. The drugs were prepared with distilled water before the experiment and administered by gavage.

[0073] Experimental method: 40 Kunming mice, half male and half female, weighing 18-22g, were randomly divided into 4 groups, 10 mice in each group. The control group was gavaged with the same volume of distilled water; the powder group I, II and III of the present invention were gavaged with 1.5g crude drug / kg respectively. The drug was administered continuously for 7 days, once a day. 1.5h after the last administration, the mice were fixed, the tails were exposed, and the probe of the microcirculation blood flowmeter was placed in the middle of the mouse tail to measure the microcirculation blood flow as normal value. Then, 0.1ml of posterior pituitary hormone (containing 0.05IU) was injected into the tail vein of all mice, and the microcirculation blood flow was measured again 2min later. The experimental results are shown below.

[0074] Table 3. Effects on microcirculatory disorders in mice

[0075] Group Microcirculatory blood flow (AU) Control group 0.189±0.082 Group I 0.482±0.114 Group II 0.478±0.119 Group III 0.475±0.121

[0076] From the above, it can be seen that the powder of the present invention can significantly antagonize the microcirculation disorder caused by posterior pituitary hormone and increase blood flow, and there is a very significant difference compared with the control group (P<0.01); it can be seen that the powder of the present invention has a good effect of improving microcirculation.

[0077] 4. Effects on Thrombosis in Rats

[0078] Experimental animals: Wistar rats weighing 200-240 g, both male and female, were selected.

[0079] Experimental drugs: the powders of Example 1 (Group I), Example 2 (Group II), and Example 3 (Group III) of the present invention, each gram of which is equivalent to 1 gram of raw medicinal materials. The drugs were prepared with distilled water before the experiment and administered by gavage.

[0080] Experimental method: 50 Wistar rats, half male and half female, weighing 200-240g, were randomly divided into 5 groups, 10 rats in each group. The control group was gavaged with the same volume of distilled water; the powder group I, II and III of the present invention were gavaged with 3g crude drug / kg respectively. The drug was administered continuously for 7 days, once a day. One hour after the last administration, 30mg / kg of 3% pentobarbital was injected intraperitoneally for anesthesia. The neck skin was cut open, one side of the carotid artery was separated, and the carotid artery was gently lifted with two electrodes. The stimulating electrode was placed at the proximal end, and the temperature side head connected to the instrument was placed at the distal end. Turn on the instrument switch, give 1.5mA direct current stimulation for 7min through the stimulating electrode to damage the endothelial cells, and measure the occlusive thrombosis time, that is, the time from the start of the current stimulation to the sudden drop in temperature. The experimental results are shown below.

[0081] Table 4. Effects on thrombosis in rats

[0082] Group Occlusive thrombosis time (min) Control group 11.52±1.87 Group I 16.75±1.97 Group II 16.59±1.84 Group III 16.62±1.89

[0083] It can be seen from the above that the powder group I, group II and group III of the present invention can significantly prolong the time of occlusive thrombosis, which is significantly different from the control group (P < 0.01); it can be seen that the present invention has a good effect of inhibiting thrombosis.

[0084] In summary, the present invention has the effects of promoting blood circulation and removing blood stasis, promoting microcirculation, reducing the burden on the heart, effectively improving blood vessel elasticity, resisting thrombosis, and protecting cardiovascular and cerebrovascular vessels.

[0085] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example" or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, unless they are contradictory.

[0086] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.

Claims

1. A Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels, characterized in that: The invention comprises the following raw materials in parts by weight: 1.0-2.0 parts of kudzu root, 1.0-2.0 parts of eucommia leaf, 0.5-1.5 parts of peach kernel, 0.5-1.0 parts of angelica, 0.5-1.0 parts of earthworm protein, 0.5-1.0 parts of eucommia male flower, 0.5-1.0 parts of double rose, 0.5-1.0 parts of sophora japonica flower, 0.5-1.0 parts of gastrodia elata, 0.5-1.0 parts of tempeh, 0.5-1.0 parts of turmeric rhizome and 0.25-0.5 parts of saffron.

2. The method for preparing a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels as claimed in claim 1, characterized in that: The steps include: Step 1: Select high-quality kudzu root, eucommia leaf, peach kernel, angelica, earthworm protein, eucommia male flower, double rose flower, Sophora japonica flower, Gastrodia elata, Tempeh, turmeric rhizome, and saffron, wash, dry, crush, and sieve them to obtain powdered raw materials, disinfect and sterilize them, and set them aside after passing the safety test; Step 2, extracting each powdered raw material three times with water, mixing the three extracts, and then heating and concentrating them. After the concentration is completed, spray drying is performed to obtain each raw material powder; Step 3: Mix the raw material powders evenly according to the proportion to obtain a mixed powder, then sterilize and disinfect it, and package it after testing to obtain the finished powder.

3. The method for preparing a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels according to claim 2, characterized in that: In the step 1, each raw material is crushed and passed through a 80-100 mesh sieve.

4. The method for preparing a Chinese medicine composition for promoting blood circulation and removing blood stasis, improving vascular elasticity, and protecting cardiovascular and cerebrovascular vessels according to claim 2, characterized in that: In the step 2, the water extraction process includes: extracting the powdered raw material with hot water at 80-95°C, filtering the liquid, and obtaining an extract.